Katherine Janeway is an Oncology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Dana Farber Cancer Institute
44 Binney Street
Boston, MA 02115
Telephone
617-632-4994Registry record last updated 17 May 2016.
Clinical trials
- Olaparib With Ceralasertib in Recurrent Osteosarcoma
Sponsor: Dana-Farber Cancer Institute
- The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
Sponsor: Dana-Farber Cancer Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- RECORDATI_RARE_DISEASES_INC.Program year20258 payments$10,676openpaymentsdata.cms.gov ↗
- Bayer HealthCare Pharmaceuticals Inc.Program year20221 payment
- ADC Therapeutics America, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2020–2025 per NIH RePORTER. The latest:
- Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults
Broad Institute, Inc.
FY2025$3,418,624U2CCA252974 - Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults
Broad Institute, Inc.
FY2024$2,950,685U2CCA252974 - Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults
Broad Institute, Inc.
FY2023$1,849,405U2CCA252974
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”